VANCOUVER, BC / ACCESSWIRE / June 17, 2024 / Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million recorded in the same quarter of 2023. This represents a growth of 4%. The revenue increase was primarily driven by a boost in sales due to promotional activities in the respiratory segment, Allerject, and sustained growth from other core products such as Redesca and Simbrinza.
Venus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for the first time for enoxaparin, an anticoagulant that plays a crucial role in addressing blood clot formation in patients suffering from deep vein thrombosis, acute coronary syndrome, heart attacks and pulmonary embolism.
The long-frozen biotech IPO waters may be thawing slightly—provided you’re one part of a rare breed of biotech. Shortly after RayzeBio filed to go public, Neumora Therapeutics, another well-financed, late-phase business, made its pitch for funding to study treatments for brain diseases including depression.
LANGHORNE, Pa.--(BUSINESS WIRE)--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, 40mg, 60mg, 80mg, 100mg, 120mg, and 150mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, a therapeutic equivalent for the reference listed drug (RLD) Lovenox® (Preservative Free) from Sanofi-Aventis US LLC. The U.S. Food and Drug Administration recently granted Techdow USA final approval of the Abbreviated New Drug Application for this product.
BE Pharms' Generic Enoxaparin Sodium Receives Approval in the U.S.
Techdow USA Announces FDA Approval of Generic Lovenox®, (Enoxaparin Sodium – Preservative Free) In Prefilled Syringes
New Delhi, Drug firm Venus Remedies on Monday said it has received good manufacturing practices (GMF) certification from the Saudi drug regulator for its production facilities at Baddi, Himachal Pradesh. The Saudi Food and Drug Authority (SFDA) granted the certification which includes first-time approval for pre-filled enoxaparin syringes and general injection facilities, the company said in a regulatory filing.
Nanjing King Generic Enoxaparin Sodium Receives Approval in the U.S.
Heparin crude, (porcine origin) is a strategic starting material for Heparin sodium API and Low Molecular Weigth Heparin APIs (LMWH) (e.g. Enoxaparin).
Amid the rising cases of Covid-19 and Omicron variant in the country, the Directorate General of Foreign Trade (DGFT) has imposed restriction on export of anticoagulant enoxaparin and intravenous immunoglobulin (IVIG) active pharmaceutical ingredients and their formulations to ensure their adequate supply in the domestic market.